Myocardial Infarction (STEMI Sample Clauses

Myocardial Infarction (STEMI. Acute Coronary Syndrome - Clinical Care Aspirin ASA is Data Source: ePCR > 99% MCEMS CQI suggests current performance is > 99% KPIs Administration administered to software all patients with Denominator: Number of complaints of patients with complaints chest of chest pain/discomfort pain/discomfort or other symptoms suggestive of or other symptoms suggestive of ACS Numerator: Number of Denominator patients to CA EMS Performance measure ACS-1 ACS whom were ambulance crew administered ASA at any time during prehospital care Performing 12- Patients with Data Source: ePCR > 95% MCEMS CQI data suggest current performance is > Lead ECG in the complaints of software field chest pain, Denominator: Number of shortness of patients with complaints breath, neck/arm of chest pain/discomfort pain, or other symptoms “weakness”/fatig ue, epigastric pain or other symptoms suggestive of suggestive of ACS and ambulance is first on scene Numerator: Number of Denominator patients for whom CA EMS Performance measure ACS-2 95% ACS receive a 12 ambulance crew Lead ECG in the administers a 12 lead field ECG at any time during prehospital care Timeliness of In patients for Data Source: ePCR 10:00 minutes or This time reference is current benchmark obtaining 12- whom a field software less in > 70% of Lead ECG in ECG is indicated, Denominator: Number of cases patients with interval from patients with complaints suspected arrival of the first of chest pain/discomfort ACS/STEMI unit on-scene to or other symptoms initiation of 12- suggestive of ACS and Lead ECG is < ambulance is first on 10:00 minutes scene Numerator: Number of Denominator patients for whom a 12 lead ECG is initiated within 10:00 minutes of ambulance arrival on scene Receiving Receiving Data Source: ePCR > 95% of cases hospital hospital is software notification by notified by EMS Denominator: Number of EMS personnel personnel of the patients with complaints impending of chest pain/discomfort transport of a suspected ACS/STEMI patient or other symptoms suggestive of ACS Numerator: Number of Denominator cases in This percentage is current benchmark CA EMS Performance measure ACS-4 which the receiving hospital is notified of impending arrival of and ACS/STEMI patient Timeliness of For patients with Data Source: ePCR 5:00 minutes or This time reference is current benchmark alerting receiving suspected software less in >70% of hospital re: a ACS/STEMI and Denominator: Number of cases requiring patient with a positive field pa...
Sample 1
AutoNDA by SimpleDocs

Related to Myocardial Infarction (STEMI

  • Rhytidectomy Scar revision, regardless of symptoms. • Sclerotherapy for spider veins. • Skin tag removal. • Subcutaneous injection of filling material. • Suction assisted Lipectomy. • Tattooing or tattoo removal except tattooing of the nipple/areola related to a mastectomy. • Treatment of vitiligo. • Standby services of an assistant surgeon or anesthesiologist. • Orthodontic services related to orthognathic surgery. • Cosmetic procedures when performed primarily: o to refine or reshape body structures or dental structures that are not functionally impaired; o to improve appearance or self-esteem; or o for other psychological, psychiatric or emotional reasons. • Drugs, biological products, hospital charges, pathology, radiology fees and charges for surgeons, assistant surgeons, attending physicians and any other incidental services, which are related to cosmetic surgery.

  • Influenza Vaccination The parties agree that influenza vaccinations may be beneficial for patients and employees. Upon a recommendation pertaining to a facility or a specifically designated area(s) thereof from the Medical Officer of Health or in compliance with applicable provincial legislation, the following rules will apply:

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

  • Influenza Vaccine Upon recommendation of the Medical Officer of Health, all employees shall be required, on an annual basis to be vaccinated and or to take antiviral medication for influenza. If the costs of such medication are not covered by some other sources, the Employer will pay the cost for such medication. If the employee fails to take the required medication, she may be placed on an unpaid leave of absence during any influenza outbreak in the home until such time as the employee has been cleared by the public health or the Employer to return to the work environment. The only exception to this would be employees for whom taking the medication will result in the employee being physically ill to the extent that she cannot attend work. Upon written direction from the employee’s physician of such medical condition in consultation with the Employer’s physician, (if requested), the employee will be permitted to access their sick bank, if any, during any outbreak period. If there is a dispute between the physicians, the employee will be placed on unpaid leave. If the employee gets sick as a reaction to the drug and applies for WSIB the Employer will not oppose the application. If an employee is pregnant and her physician believes the pregnancy could be in jeopardy as a result of the influenza inoculation and/or the antiviral medication she shall be eligible for sick leave in circumstances where she is not allowed to attend at work as a result of an outbreak. This clause shall be interpreted in a manner consistent with the Ontario Human Rights Code.

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • Biological Samples If so specified in the Protocol, Institution and Principal Investigator may collect and provide to Sponsor or its designee Biological Samples (“Biological Samples”). 12.2.

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Drug Testing (A) The state and the PBA agree to drug testing of employees in accordance with section 112.0455, F.S., the Drug-Free Workplace Act.

  • Trials The Ship shall run the following test and trials:

  • Drug Test The compulsory production and submission of urine and/or blood, in accordance with departmental procedures, by an employee for chemical analysis to detect prohibited drug usage.

Time is Money Join Law Insider Premium to draft better contracts faster.